Keywords: USA, FDA, Rare and neglected diseases, Senate Appropriations Bill, NORD

US Senate FY 2011 FDA Appropriations Bill should be another big step forward for rare and neglected disease patients, says FDA Law Blog

Article | 20 July 2010

With the US Senate Committee on Appropriations beginning its markup and consideration of appropriations bills for Fiscal Year 2011, and in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in